Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression
Open Access
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Experimental & Molecular Medicine
- Vol. 41 (10), 717-727
- https://doi.org/10.3858/emm.2009.41.10.078
Abstract
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.Keywords
This publication has 29 references indexed in Scilit:
- PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Role of Triptolide as an Adjunct Chemotherapy for Ovarian CancerChemotherapy, 2007
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- Revisiting the ancient concept of botanical therapeuticsNature Chemical Biology, 2007
- A cytokine-mediated link between innate immunity, inflammation, and cancerJCI Insight, 2007
- Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)Phytochemistry, 2007
- Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cellsBlood, 2006
- Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-κB signaling pathwaysAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- The Rac Exchange Factor Tiam1 Is Required for the Establishment and Maintenance of Cadherin-based AdhesionsPublished by Elsevier BV ,2004
- Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordiiCancer Letters, 1997